Manglio Rizzo

1.3k total citations
44 papers, 910 citations indexed

About

Manglio Rizzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Manglio Rizzo has authored 44 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Manglio Rizzo's work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Immunotherapy and Immune Responses (6 papers). Manglio Rizzo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Immunotherapy and Immune Responses (6 papers). Manglio Rizzo collaborates with scholars based in Argentina, United States and Spain. Manglio Rizzo's co-authors include Guillermo Mazzolini, Laura Alaniz, Mariana Malvicini, Mariana Garcı́a, Juan Bayo, Catalina Atorrasagasti, Jorge B. Aquino, Esteban Fiore, Flavia Piccioni and Estanislao Peixoto and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Manglio Rizzo

39 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manglio Rizzo Argentina 16 388 351 214 155 128 44 910
Evangeline Mose United States 18 551 1.4× 563 1.6× 283 1.3× 239 1.5× 123 1.0× 25 1.2k
Luciana L. Almada United States 19 337 0.9× 753 2.1× 137 0.6× 157 1.0× 67 0.5× 45 1.1k
Kabir A. Khan United Kingdom 15 489 1.3× 547 1.6× 320 1.5× 217 1.4× 93 0.7× 21 1.2k
Florian Ewald Germany 16 228 0.6× 492 1.4× 117 0.5× 201 1.3× 42 0.3× 25 792
Esteban Fiore Argentina 20 151 0.4× 397 1.1× 108 0.5× 180 1.2× 105 0.8× 37 860
Magali Castells France 9 254 0.7× 279 0.8× 223 1.0× 203 1.3× 45 0.4× 9 723
Yingtang Gao China 19 307 0.8× 488 1.4× 244 1.1× 304 2.0× 59 0.5× 66 1.1k
Lidia Moserle Italy 18 496 1.3× 647 1.8× 173 0.8× 341 2.2× 63 0.5× 26 1.1k
Da‐Liang Ou Taiwan 20 508 1.3× 656 1.9× 300 1.4× 320 2.1× 52 0.4× 53 1.3k
Nadia Coltella Italy 16 194 0.5× 387 1.1× 109 0.5× 206 1.3× 37 0.3× 24 709

Countries citing papers authored by Manglio Rizzo

Since Specialization
Citations

This map shows the geographic impact of Manglio Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manglio Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manglio Rizzo more than expected).

Fields of papers citing papers by Manglio Rizzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manglio Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manglio Rizzo. The network helps show where Manglio Rizzo may publish in the future.

Co-authorship network of co-authors of Manglio Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Manglio Rizzo. A scholar is included among the top collaborators of Manglio Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manglio Rizzo. Manglio Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rubio, Pablo, et al.. (2025). Cancer as a novel risk factor for major cardiovascular adverse events in secondary prevention. International Journal of Cardiology Cardiovascular Risk and Prevention. 27. 200501–200501.
2.
Bueno, Fernanda, et al.. (2023). Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience. Endocrine. 80(1). 134–141. 9 indexed citations
3.
Rizzo, Manglio, et al.. (2023). Retreatment with EGFR inhibitor in non-small cell lung cancer patients previously exposed to EGFR-TKI: A systematic review and meta-analysis.. Journal of Clinical Oncology. 41(16_suppl). e21159–e21159. 1 indexed citations
4.
Malvicini, Mariana, et al.. (2023). Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features. Current Treatment Options in Oncology. 24(11). 1550–1567. 2 indexed citations
5.
Rizzo, Manglio, et al.. (2022). Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer. Breast Care. 17(6). 546–553. 3 indexed citations
6.
Rizzo, Manglio, et al.. (2021). Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era. The Breast. 60. 15–25. 36 indexed citations
7.
Rizzo, Manglio, et al.. (2021). Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting. International Journal of Clinical Oncology. 26(6). 1057–1064. 2 indexed citations
8.
9.
Rízzí, María, et al.. (2019). P1.04-82 Toxicity as a Clinical Marker for Efficacy of Immunotherapy in NSCLC: A Multicentric Experience from Argentina. Journal of Thoracic Oncology. 14(10). S474–S475. 1 indexed citations
10.
Rízzí, María, et al.. (2019). EP1.04-41 Efficacy of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer: A Multicentric Experience from Argentina. Journal of Thoracic Oncology. 14(10). S984–S984.
11.
Bayo, Juan, Esteban Fiore, Mariana Malvicini, et al.. (2019). A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. Journal of Hepatology. 71(1). 78–90. 76 indexed citations
12.
Rizzo, Manglio, Gerardo Cueto, Alicia Bravo, et al.. (2019). Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients. Cancer Immunology Immunotherapy. 68(10). 1585–1596. 36 indexed citations
13.
Rizzo, Manglio, María Paula Roberti, M. Betina Pampena, et al.. (2018). High neutrophil to lymphocyte ratio and decreased CD69<sup>+</sup>NK cells represent a phenotype of high risk in early-stage breast cancer patients. OncoTargets and Therapy. Volume 11. 2901–2910. 11 indexed citations
14.
Piccioni, Flavia, Esteban Fiore, Juan Bayo, et al.. (2015). 4-Methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis. Glycobiology. 25(8). 825–835. 46 indexed citations
15.
Sanmamed, Miguel F., Carlos Alfaro, Carmen Oñate, et al.. (2014). Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins. Clinical Cancer Research. 20(22). 5697–5707. 204 indexed citations
16.
Fiore, Esteban, Juan Bayo, Mariana Garcı́a, et al.. (2014). Mesenchymal Stromal Cells Engineered to Produce IGF-I by Recombinant Adenovirus Ameliorate Liver Fibrosis in Mice. Stem Cells and Development. 24(6). 791–801. 68 indexed citations
17.
Bayo, Juan, Esteban Fiore, Jorge B. Aquino, et al.. (2014). Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma. PLoS ONE. 9(4). e95171–e95171. 41 indexed citations
18.
Rizzo, Manglio, Laura Alaniz, & Guillermo Mazzolini. (2014). Ex Vivo Loading of Autologous Dendritic Cells with Tumor Antigens. Methods in molecular biology. 1139. 41–44. 2 indexed citations
19.
Rizzo, Manglio, Juan Bayo, Flavia Piccioni, et al.. (2014). Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction. PLoS ONE. 9(9). e107944–e107944. 18 indexed citations
20.
Rizzo, Manglio, et al.. (2010). Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization. Cancer Chemotherapy and Pharmacology. 67(3). 723–728. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evangeline Mose Breakdown of academic impact, for papers by Luciana L. Almada Breakdown of academic impact, for papers by Kabir A. Khan Breakdown of academic impact, for papers by Florian Ewald Breakdown of academic impact, for papers by Esteban Fiore Breakdown of academic impact, for papers by Magali Castells Breakdown of academic impact, for papers by Yingtang Gao Breakdown of academic impact, for papers by Lidia Moserle Breakdown of academic impact, for papers by Da‐Liang Ou Breakdown of academic impact, for papers by Nadia Coltella
Rankless by CCL
2026